treprostinil 0.08 MG Inhalation Powder [Tyvaso]
RxNorm concept 2697739, branded drug (sbd). Prescribable name: TYVASO DPI 80 MCG Inhalation Powder.
- RxCUI
- 2697739
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2697739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Tyvaso 0.08 MG Inhalation Powder; Tyvaso 80 MCG Inhalation Powder
Related concepts
- treprostinil 0.08 MG (SCDC, consists of)
- treprostinil 0.08 MG [Tyvaso] (SBDC, consists of)
- {112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.08 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 48-80 MCG Maintenance Pack] (BPCK, contained in)
- {112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.08 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 64-80 MCG Maintenance Pack] (BPCK, contained in)
- Inhalation Powder (DF, has dose form)
- Tyvaso (BN, has ingredient)
- treprostinil 0.08 MG Inhalation Powder (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2697739 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2697739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2697739. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.